Literature DB >> 12099383

Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology.

R C Drachenberg1, C B Drachenberg, J C Papadimitriou, E Ramos, J C Fink, R Wali, M R Weir, C B Cangro, D K Klassen, A Khaled, R Cunningham, S T Bartlett.   

Abstract

The morphological features of polyoma virus disease (PVDz) in 571 concurrent urine and biopsy samples from 413 patients are described. In 54 patients PV was found in both biopsy and urine samples. Histologically, PV presented as: (a) mild, viral cytopathic/cytolytic changes, with absent or minimal inflammation involving isolated tubules; (b) moderate and severe, cytopathic/cytolytic changes associated with patchy or diffuse tubulo-interstitial inflammation and atrophy; (c) advanced, graft sclerosis with rare or absent viral cytopathic changes, indistinguishable from chronic allograft nephropathy. Histological progression from mild to moderate or severe disease was seen in 28 patients. The mean post-transplantation time at diagnosis was similar in patients with mild or moderate-severe renal involvement (1.05 and 1.3 years, respectively). All patients presented with similarly increased values of serum creatinine (mean 1.35 mg/dL). There was strong correlation between the number of PV infected cells in urine and the concurrent biopsies (p = 0.0001). In 13 patients PV was found only in urine; of these, two developed PVDz later. The positive predictive value of a positive urine was 90%, the negative predictive value of a negative urine was 99% and the accuracy of the test was 97%. We conclude that urine cytology is useful to evaluate renal transplant patients with PV reactivation because sloughed tubular cells are found in urine and positive urine samples are a consistent manifestation of PV renal involvement.

Entities:  

Mesh:

Year:  2001        PMID: 12099383

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  30 in total

1.  [Polyomavirus associated nephropathy. A new opportunistic complication after kidney transplantation].

Authors:  H H Hirsch
Journal:  Internist (Berl)       Date:  2003-05       Impact factor: 0.743

Review 2.  BK polyomavirus infection and nephropathy: the virus-immune system interplay.

Authors:  Nina Babel; Hans-Dieter Volk; Petra Reinke
Journal:  Nat Rev Nephrol       Date:  2011-05-24       Impact factor: 28.314

3.  The Banff Working Group Classification of Definitive Polyomavirus Nephropathy: Morphologic Definitions and Clinical Correlations.

Authors:  Volker Nickeleit; Harsharan K Singh; Parmjeet Randhawa; Cinthia B Drachenberg; Ramneesh Bhatnagar; Erika Bracamonte; Anthony Chang; W James Chon; Darshana Dadhania; Vicki G Davis; Helmut Hopfer; Michael J Mihatsch; John C Papadimitriou; Stefan Schaub; Michael B Stokes; Mohammad F Tungekar; Surya V Seshan
Journal:  J Am Soc Nephrol       Date:  2017-12-26       Impact factor: 10.121

4.  Sequence Variation in Amplification Target Genes and Standards Influences Interlaboratory Comparison of BK Virus DNA Load Measurement.

Authors:  Morgane Solis; Mariam Meddeb; Charlotte Sueur; Pilar Domingo-Calap; Eric Soulier; Angeline Chabaud; Peggy Perrin; Bruno Moulin; Seiamak Bahram; Françoise Stoll-Keller; Sophie Caillard; Heidi Barth; Samira Fafi-Kremer
Journal:  J Clin Microbiol       Date:  2015-10-14       Impact factor: 5.948

5.  The Banff 2009 Working Proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome.

Authors:  K Masutani; R Shapiro; A Basu; H Tan; M Wijkstrom; P Randhawa
Journal:  Am J Transplant       Date:  2012-03-05       Impact factor: 8.086

6.  Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.

Authors:  Yiping Chen; Jennifer Trofe; Jennifer Gordon; Renaud A Du Pasquier; Prabir Roy-Chaudhury; Marcelo J Kuroda; E Steve Woodle; Kamel Khalili; Igor J Koralnik
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies.

Authors:  Parmjeet Randhawa; Raphael Viscidi; Joseph J Carter; Denise A Galloway; Tim D Culp; Cathy Huang; Bala Ramaswami; Neil D Christensen
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

8.  Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients.

Authors:  Parmjeet Randhawa; Andrew Ho; Ron Shapiro; Abhay Vats; P Swalsky; Sydney Finkelstein; John Uhrmacher; Karen Weck
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

9.  BK polyoma viral infection in renal allograft recipients.

Authors:  Sonia Badwal; G S Chopra; P P Varma; A K Hooda
Journal:  Med J Armed Forces India       Date:  2011-07-21

10.  Risk factors for polyoma virus nephropathy.

Authors:  Olivier Prince; Spasenija Savic; Michael Dickenmann; Jürg Steiger; Lukas Bubendorf; Michael J Mihatsch
Journal:  Nephrol Dial Transplant       Date:  2008-12-10       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.